Stada Generics Takes A Hit Even As Firm Steals A March On Rivals

Group’s Sales ‘Better Than The Average For The Top-Five Suppliers’

earnings
Stada Generics adjusted EBITDA fell by 12% • Source: Alamy

More from Biosimilars

More from Products